Why Vaccine Stocks Rallied This Week

A bird flu outbreak could spur demand for vaccines from these key players, but is it likely? Shares of vaccine stocks Moderna (MRNA 0.42%), Novavax (NVAX -3.50%), and BioNTech SE (BNTX -3.23%) rallied this week, appreciating 23.4%, 16.4%, and 9.3%, respectively, through Thursday trading, according to data from S&P Global Market Intelligence. Unlike the COVID-19 pandemic, when the U.S. government subsidized private companies to make the COVID- 19 vaccine, the government actually has a stockpile of H5N1 virus ...